Effect of Sharbat Tamar hindi in Nausea and Vomiting during pregnancy

Effect of Sharbat Tamar hindi in Nausea and Vomiting during Pregnancy: A pre and post interventional study - nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/079999

Enrollment

Registered

2025-02-06

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O219- Vomiting of pregnancy, unspecified

Interventions

Intervention1: Sharbat Tamar hindi: Sharbat will be prepared as per the standard method mentioned in classical Unani pharmacopea.25 ml sharbat will be administered orally with water twice, half an hou

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant women in age group of 18-35 years with singleton fetus between 6-10 weeks of gestation having nausea and vomiting of mild to moderate (3-12) PUQE score

Exclusion criteria

Exclusion criteria: Patient with PUQE Score more than 3 History of peptic ulcer gastroenteritis pancreatitis cholecystitis appendicitis renal stone systemic diseases like HTN GDM thyroid dysfunction Multiple pregnancy abortion ectopic pregnancy molar pregnancy

Design outcomes

Primary

Measure	Time frame
Reduction in PUQE 24 scoreTimepoint: At baseline, 2 weeks, 4 weeks	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactProf Ismath Shameem

National Institude of Unani Medicine

dr.ismaths@gmail.com9449977008

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026